China · Delayed Price · Currency is CNY Hybio Pharmaceutical Statistics
Total Valuation
SHE:300199 has a market cap or net worth of CNY 18.18 billion. The enterprise value is 20.04 billion.
| Market Cap | 18.18B |
| Enterprise Value | 20.04B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300199 has 883.24 million shares outstanding. The number of shares has increased by 1.52% in one year.
| Current Share Class | 883.24M |
| Shares Outstanding | 883.24M |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | -6.97% |
| Owned by Insiders (%) | 24.44% |
| Owned by Institutions (%) | 3.66% |
| Float | 647.39M |
Valuation Ratios
The trailing PE ratio is 201.23.
| PE Ratio | 201.23 |
| Forward PE | n/a |
| PS Ratio | 19.02 |
| PB Ratio | 24.01 |
| P/TBV Ratio | 44.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 68.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 56.98, with an EV/FCF ratio of -1,438.62.
| EV / Earnings | 212.06 |
| EV / Sales | 20.98 |
| EV / EBITDA | 56.98 |
| EV / EBIT | 89.13 |
| EV / FCF | -1,438.62 |
Financial Position
The company has a current ratio of 0.43, with a Debt / Equity ratio of 2.59.
| Current Ratio | 0.43 |
| Quick Ratio | 0.19 |
| Debt / Equity | 2.59 |
| Debt / EBITDA | 6.44 |
| Debt / FCF | -140.64 |
| Interest Coverage | 1.85 |
Financial Efficiency
Return on equity (ROE) is 12.92% and return on invested capital (ROIC) is 5.19%.
| Return on Equity (ROE) | 12.92% |
| Return on Assets (ROA) | 3.46% |
| Return on Invested Capital (ROIC) | 5.19% |
| Return on Capital Employed (ROCE) | 9.70% |
| Weighted Average Cost of Capital (WACC) | 7.74% |
| Revenue Per Employee | 779,387 |
| Profits Per Employee | 77,093 |
| Employee Count | 1,226 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.44 |
Taxes
In the past 12 months, SHE:300199 has paid 32.79 million in taxes.
| Income Tax | 32.79M |
| Effective Tax Rate | 26.28% |
Stock Price Statistics
The stock price has increased by +43.88% in the last 52 weeks. The beta is 0.72, so SHE:300199's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +43.88% |
| 50-Day Moving Average | 21.71 |
| 200-Day Moving Average | 21.00 |
| Relative Strength Index (RSI) | 44.09 |
| Average Volume (20 Days) | 54,106,571 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300199 had revenue of CNY 955.53 million and earned 94.52 million in profits. Earnings per share was 0.10.
| Revenue | 955.53M |
| Gross Profit | 551.37M |
| Operating Income | 177.49M |
| Pretax Income | 124.78M |
| Net Income | 94.52M |
| EBITDA | 303.57M |
| EBIT | 177.49M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 108.74 million in cash and 1.96 billion in debt, with a net cash position of -1.85 billion or -2.10 per share.
| Cash & Cash Equivalents | 108.74M |
| Total Debt | 1.96B |
| Net Cash | -1.85B |
| Net Cash Per Share | -2.10 |
| Equity (Book Value) | 757.11M |
| Book Value Per Share | 0.84 |
| Working Capital | -878.61M |
Cash Flow
In the last 12 months, operating cash flow was 263.91 million and capital expenditures -277.84 million, giving a free cash flow of -13.93 million.
| Operating Cash Flow | 263.91M |
| Capital Expenditures | -277.84M |
| Depreciation & Amortization | 126.08M |
| Net Borrowing | -119.50M |
| Free Cash Flow | -13.93M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 57.70%, with operating and profit margins of 18.57% and 9.89%.
| Gross Margin | 57.70% |
| Operating Margin | 18.57% |
| Pretax Margin | 13.06% |
| Profit Margin | 9.89% |
| EBITDA Margin | 31.77% |
| EBIT Margin | 18.57% |
| FCF Margin | n/a |
Dividends & Yields
SHE:300199 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 102.92% |
| Buyback Yield | -1.52% |
| Shareholder Yield | -1.52% |
| Earnings Yield | 0.52% |
| FCF Yield | -0.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 14, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Apr 14, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
SHE:300199 has an Altman Z-Score of 3.35 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.35 |
| Piotroski F-Score | 7 |